Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000151211 | SCV000199047 | likely benign | not specified | 2013-04-20 | criteria provided, single submitter | clinical testing | Ser1838Ser in exon 36 of MYH6: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. Ser1838Ser in exon 36 of MYH6 (allele frequ ency = n/a) |
Invitae | RCV001087865 | SCV000768887 | likely benign | Hypertrophic cardiomyopathy 14 | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000829203 | SCV000970919 | likely benign | not provided | 2019-12-26 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001171174 | SCV001333866 | likely benign | Cardiomyopathy | 2018-04-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345466 | SCV002651105 | likely benign | Cardiovascular phenotype | 2020-03-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000829203 | SCV004129058 | likely benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | MYH6: BP4, BP7 |